Skip to main content

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

48.03 +0.49 (+1.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist

Other Filings

Form 424B3
Source: SEC/Edgar
March 30, 2004
Form 10KSB
Source: SEC/Edgar
March 29, 2004
Form SC 13G/A
Source: SEC/Edgar
March 29, 2004
Form 8-K
Source: SEC/Edgar
March 25, 2004
Form S-2/A
Source: SEC/Edgar
March 21, 2004
Form SC 13G
Source: SEC/Edgar
March 18, 2004
Form SC 13G
Source: SEC/Edgar
March 18, 2004
Form SC 13G
Source: SEC/Edgar
March 18, 2004
Form 8-K
Source: SEC/Edgar
March 16, 2004
Form SC 13G/A
Source: SEC/Edgar
March 11, 2004
Form 8-K
Source: SEC/Edgar
March 11, 2004
Form SC 13G/A
Source: SEC/Edgar
March 07, 2004
Form SC 13G/A
Source: SEC/Edgar
March 07, 2004
Form SC TO-I/A
Source: SEC/Edgar
March 04, 2004
Form SC TO-I/A
Source: SEC/Edgar
March 03, 2004
Form S-2/A
Source: SEC/Edgar
February 24, 2004
Form DEFM14C
Source: SEC/Edgar
February 16, 2004
Form 10QSB
Source: SEC/Edgar
February 11, 2004
Form 8-K
Source: SEC/Edgar
February 11, 2004
Form S-2
Source: SEC/Edgar
February 11, 2004
Form PREM14C
Source: SEC/Edgar
February 05, 2004
Form SC TO-I
Source: SEC/Edgar
February 04, 2004
Form 8-K
Source: SEC/Edgar
February 01, 2004
Form SC 13G
Source: SEC/Edgar
January 12, 2004
Form 8-K
Source: SEC/Edgar
December 18, 2003
Form 8-K
Source: SEC/Edgar
December 04, 2003
Form REGDEX
Source: SEC/Edgar
November 30, 2003
Form 10QSB
Source: SEC/Edgar
November 13, 2003
Form 10QSB
Source: SEC/Edgar
November 13, 2003
Form 10KSB
Source: SEC/Edgar
October 13, 2003
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.